{
    "startDate": "2021-01-01",
    "endDate": "2021-06-30",
    "year": "2021",
    "quarter": "Q2",
    "symbol": "AMRX",
    "data": {
        "bs": [
            {
                "label": "Redeemable non-controlling interests",
                "concept": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
                "unit": "usd",
                "value": 14112000
            },
            {
                "label": "Redeemable non-controlling interests",
                "concept": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
                "unit": "usd",
                "value": 14112000
            },
            {
                "label": "Redeemable non-controlling interests",
                "concept": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
                "unit": "usd",
                "value": 14112000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 549091000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 549091000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 468415000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 103798000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 103798000
            },
            {
                "label": "Preferred stock, par value (in usd per share)",
                "concept": "PreferredStockParOrStatedValuePerShare",
                "unit": "usd/shares",
                "value": 0.01
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 642657000
            },
            {
                "label": "Total Amneal Pharmaceuticals, Inc. stockholders' equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 346107000
            },
            {
                "label": "Long-term debt, net",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 2720117000
            },
            {
                "label": "Total long-term liabilities",
                "concept": "LiabilitiesNoncurrent",
                "unit": "usd",
                "value": 2945807000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 63255000
            },
            {
                "label": "Related party payable - long term",
                "concept": "DueToAffiliateNoncurrent",
                "unit": "usd",
                "value": 8714000
            },
            {
                "label": "Trade accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 652015000
            },
            {
                "label": "Trade accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 652015000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 19216000
            },
            {
                "label": "Non-controlling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 44165000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 1293325000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 1293325000
            },
            {
                "label": "Note payable - related party",
                "concept": "NotesPayableRelatedPartiesNoncurrent",
                "unit": "usd",
                "value": 37224000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 523385000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 523385000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 390272000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 390272000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 390272000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 596227000
            },
            {
                "label": "Current portion of long-term debt, net",
                "concept": "LongTermDebtCurrent",
                "unit": "usd",
                "value": 30461000
            },
            {
                "label": "Total liabilities and stockholders' equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 4023053000
            },
            {
                "label": "Preferred stock, $0.01 par value, 2,000 shares authorized; none issued at both June 30, 2021 and December 31, 2020",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 672862000
            },
            {
                "label": "Commitments and contingencies (Notes 5 and 13)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Related party receivables",
                "concept": "DueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 1124000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 278306000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 278306000
            },
            {
                "label": "Stockholders' accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -265583000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 4847000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 4847000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 4023053000
            },
            {
                "label": "Related party payable - short term",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 32930000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 1563475000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -33979000
            }
        ],
        "cf": [
            {
                "label": "Income taxes receivable associated with the CARES Act",
                "concept": "IncreaseDecreaseInIncomeTaxesReceivable",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Trade accounts receivable, net",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 13167000
            },
            {
                "label": "Tax distribution to non-controlling interests",
                "concept": "amrx:TaxDistributionToNonControllingInterest",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 61441000
            },
            {
                "label": "Cash paid for income taxes, net",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": 4610000
            },
            {
                "label": "Amortization of debt issuance costs and discount",
                "concept": "AmortizationOfFinancingCostsAndDiscounts",
                "unit": "usd",
                "value": 4473000
            },
            {
                "label": "Tax distributions to non-controlling interests",
                "concept": "amrx:TaxDistributionToNoncontrollingInterestFinancingActivities",
                "unit": "usd",
                "value": 27551000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 12962000
            },
            {
                "label": "Acquisitions, net of cash acquired",
                "concept": "PaymentsToAcquireBusinessesNetOfCashAcquired",
                "unit": "usd",
                "value": 73828000
            },
            {
                "label": "Gain on sale of international businesses, net",
                "concept": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Gain on sale of international businesses, net",
                "concept": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash (used in) provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -64217000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 54580000
            },
            {
                "label": "Inventory provision",
                "concept": "InventoryWriteDown",
                "unit": "usd",
                "value": 25805000
            },
            {
                "label": "Prepaid expenses, other current assets and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 23988000
            },
            {
                "label": "Employee payroll tax withholding on restricted stock unit vesting",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 2378000
            },
            {
                "label": "Proceeds from issuance of debt",
                "concept": "ProceedsFromIssuanceOfMediumTermNotes",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other operating charges and credits, net",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -2764000
            },
            {
                "label": "Effect of foreign exchange rate on cash",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": -366000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 46721000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 46721000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 46721000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "amrx:DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts",
                "unit": "usd",
                "value": 112037000
            },
            {
                "label": "Net cash provided by operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 96195000
            },
            {
                "label": "Related party payables",
                "concept": "IncreaseDecreaseInDueToRelatedParties",
                "unit": "usd",
                "value": -3912000
            },
            {
                "label": "Deferred consideration for acquisition - related party",
                "concept": "amrx:NoncashOrPartNoncashAcquisitionDeferredConsiderationForAcquisitionRelatedParty",
                "unit": "usd",
                "value": 30099000
            },
            {
                "label": "Deposits for future acquisition of property, plant, and equipment",
                "concept": "amrx:PaymentsToAcquirePropertyPlantAndEquipmentDeposits",
                "unit": "usd",
                "value": 1667000
            },
            {
                "label": "Contingent consideration for acquisition - related party",
                "concept": "amrx:NoncashOrPartNoncashAcquisitionContingentConsiderationForAcquisitionRelatedParty",
                "unit": "usd",
                "value": 6100000
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -95580000
            },
            {
                "label": "Related party receivables",
                "concept": "IncreaseDecreaseInDueFromRelatedParties",
                "unit": "usd",
                "value": -7383000
            },
            {
                "label": "Repayment of related party note",
                "concept": "RepaymentsOfRelatedPartyDebt",
                "unit": "usd",
                "value": 1000000
            },
            {
                "label": "Net (decrease) increase in cash, cash equivalents, and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -63968000
            },
            {
                "label": "Payments of deferred financing costs",
                "concept": "PaymentsOfDebtIssuanceCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accounts payable, accrued expenses and other liabilities",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -21137000
            },
            {
                "label": "Unrealized foreign currency loss",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": -124000
            },
            {
                "label": "Payments of principal on debt, financing leases and other",
                "concept": "amrx:RepaymentsOfLongTermDebtAndFinancingLeaseObligations",
                "unit": "usd",
                "value": 33876000
            },
            {
                "label": "Acquisition of intangible assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 500000
            },
            {
                "label": "Proceeds from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 681000
            },
            {
                "label": "Intangible asset impairment charges",
                "concept": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
                "unit": "usd",
                "value": 710000
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 19585000
            }
        ],
        "ic": [
            {
                "label": "Diluted (in usd per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 0.14
            },
            {
                "label": "Diluted (in usd per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 0.14
            },
            {
                "label": "Restructuring and other charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 363000
            },
            {
                "label": "Restructuring and other charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 363000
            },
            {
                "label": "Less: Net (income) loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 25483000
            },
            {
                "label": "Less: Net (income) loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 25483000
            },
            {
                "label": "Cost of goods sold impairment charges",
                "concept": "amrx:CostOfGoodsAndServicesSoldImpairmentCharges",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Acquisition, transaction-related and integration expenses",
                "concept": "amrx:BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense",
                "unit": "usd",
                "value": 7085000
            },
            {
                "label": "Acquisition, transaction-related and integration expenses",
                "concept": "amrx:BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense",
                "unit": "usd",
                "value": 7085000
            },
            {
                "label": "Operating income",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 113026000
            },
            {
                "label": "Operating income",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 113026000
            },
            {
                "label": "Income (loss) before income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": 49728000
            },
            {
                "label": "In-process research and development impairment charges",
                "concept": "AssetImpairmentCharges",
                "unit": "usd",
                "value": 710000
            },
            {
                "label": "In-process research and development impairment charges",
                "concept": "AssetImpairmentCharges",
                "unit": "usd",
                "value": 710000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 101046000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 101046000
            },
            {
                "label": "Gain on sale of international businesses, net",
                "concept": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Gain on sale of international businesses, net",
                "concept": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestIncomeExpenseNonoperatingNet",
                "unit": "usd",
                "value": -67968000
            },
            {
                "label": "Net income (loss) attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": 21238000
            },
            {
                "label": "Net income (loss) attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": 21238000
            },
            {
                "label": "Net income (loss) attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": 21238000
            },
            {
                "label": "Basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 148507000
            },
            {
                "label": "Basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 148507000
            },
            {
                "label": "Diluted (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 151606000
            },
            {
                "label": "Diluted (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 151606000
            },
            {
                "label": "Basic (in usd per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 0.14
            },
            {
                "label": "Basic (in usd per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 0.14
            },
            {
                "label": "Other income, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 4826000
            },
            {
                "label": "Provision for (benefit from) income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 3007000
            },
            {
                "label": "Provision for (benefit from) income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 3000000
            },
            {
                "label": "Gross profit",
                "concept": "GrossProfit",
                "unit": "usd",
                "value": 404060000
            },
            {
                "label": "Gross profit",
                "concept": "GrossProfit",
                "unit": "usd",
                "value": 404060000
            },
            {
                "label": "Intellectual property legal development expenses",
                "concept": "RoyaltyExpense",
                "unit": "usd",
                "value": 4947000
            },
            {
                "label": "Intellectual property legal development expenses",
                "concept": "RoyaltyExpense",
                "unit": "usd",
                "value": 4947000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 176883000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 176883000
            },
            {
                "label": "Charges related to legal matters, net",
                "concept": "GainLossRelatedToLitigationSettlement",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Cost of goods sold",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 624120000
            },
            {
                "label": "Cost of goods sold",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 624120000
            },
            {
                "label": "Net revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 1028180000
            },
            {
                "label": "Net revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 1028180000
            },
            {
                "label": "Net revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 1028180000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 46721000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 46721000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 46721000
            },
            {
                "label": "Foreign exchange (loss) gain, net",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": -156000
            },
            {
                "label": "Total other expense, net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -63298000
            },
            {
                "label": "Less: Net (income) loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 25483000
            },
            {
                "label": "Less: Net (income) loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 25483000
            },
            {
                "label": "Other comprehensive income (loss) attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 7542000
            },
            {
                "label": "Unrealized loss on cash flow hedge, net of tax",
                "concept": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
                "unit": "usd",
                "value": 21476000
            },
            {
                "label": "Unrealized loss on cash flow hedge, net of tax",
                "concept": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
                "unit": "usd",
                "value": 21476000
            },
            {
                "label": "Less: Other comprehensive (income) loss attributable to non-controlling interests",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 7750000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 46721000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 46721000
            },
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 46721000
            },
            {
                "label": "Comprehensive income (loss) attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 28780000
            },
            {
                "label": "Foreign currency translation adjustments arising during the period",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -6184000
            },
            {
                "label": "Foreign currency translation adjustments arising during the period",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -6184000
            },
            {
                "label": "Net income (loss) attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": 21238000
            },
            {
                "label": "Net income (loss) attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": 21238000
            },
            {
                "label": "Net income (loss) attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": 21238000
            }
        ]
    }
}